Delivery Order SPE2DB20D1110-SPE2DB24FK12Z

Award Date 4/16/24
Potential Completion Date 4/17/24
Potential Value $9.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,905.48 firm fixed-price delivery order is for the supply of 4,565,007,428 units of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical supplier. The contract, valued at up to $3,670.11, is a delivery order for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 3 mg/0.5 ml pens. The $13,289.22 firm fixed price delivery order has a completion date of September 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,902.80 delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens. This award is under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,073.00 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract has an ultimate completion date of August 6, 2024. This award is under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corporation. The $2,745.99 firm-fixed price delivery order is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen, 0.5 ml. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a wide range of medical commodities to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,102.40 firm fixed-price delivery order is for the supply of the medication Trulicity (0.75 mg/0.5 ml pen, 0.5 ml), with a completion date of November 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The $2,612.52 firm fixed-price contract has an ultimate completion date of April 3, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a $1,451.40 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen. This order is placed under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 mL pens. The firm-fixed-price delivery order, valued at $1,582.68, has an ultimate completion date of September 17, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for the provision of a comprehensive range of medical...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB24FK12Z
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $9,799.43 delivery order is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen with a completion date of April 17, 2024. This award is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and expiring on December 31, 2025. The IDC allows DLA to efficiently procure a wide range of pharmaceutical products and medical supplies, including specialty and generic medications, as well as critical care materials, to support the Department of Defense's medical treatment programs and facilities worldwide. There was no set-aside designation for this specific order.

Generated 7/16/24, 12:16 PM